A shareholder of RKLB, Merline A. Saintil, has filed a Rule 144 notice to sell 12,500 shares of RKLB common stock. The planned sale is to be executed through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $1,082,250 for these shares and 534,156,333 common shares outstanding overall. The 12,500 shares were acquired from the issuer on August 22, 2023 as restricted stock units.
Over the prior three months, the same shareholder reported several sales of RKLB common stock, including multiple Rule 10b5-1 plan transactions in December 2025. These past sales ranged from 5,000 to 15,000 shares per transaction, with disclosed gross proceeds for each sale. The filing also includes a representation that the seller is not aware of any undisclosed material adverse information about the issuer.
Rocket Lab Corp’s Chief Financial Officer, Adam Spice, reported an option exercise and share sales. On January 5, 2026, he exercised 731,330 Employee Stock Options at an exercise price of $1.09 per share, receiving the same number of Rocket Lab common shares.
On the same date, he sold multiple blocks of Rocket Lab common stock in open-market transactions at weighted-average prices ranging from $72.149 to $78.0435 per share under a pre-established Rule 10b5-1 trading plan adopted on September 19, 2025. Following these transactions, he directly owned 1,359,568 shares of common stock and 2,522,825 stock options.
Rocket Lab Corp director Merline Saintil reported multiple stock sales carried out under a pre-arranged Rule 10b5-1 trading plan. On December 17, 2025, she sold blocks of 2,533, 1,767, 500 and 200 shares of Rocket Lab common stock in open-market transactions.
The reported weighted-average sale prices were $53.8164, $54.824, $55.668 and $56.48, with each group of trades executed across price ranges detailed in the footnotes. After these transactions, Saintil directly beneficially owned 393,529 shares of Rocket Lab common stock.
The filing notes that these sales occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2025, which is designed to allow insiders to sell shares according to a preset schedule.
Rocket Lab Corp reported insider stock sales by CEO and director Peter Beck, executed indirectly through the Equatorial Trust on December 15 and 16, 2025. The sales occurred automatically under a Rule 10b5-1 trading plan adopted by the trust on June 13, 2025.
The trust sold multiple blocks of Rocket Lab common stock, including 317,989 shares at a weighted-average price of $55.6411 and 537,294 shares at $56.6163, with additional sales at weighted-average prices up to $64.3144. After these transactions, the trust’s indirect holding was reported as 0 shares, while 902,942 Rocket Lab shares were reported as held directly.
Rocket Lab Corp director Merline Saintil reported a stock sale. On 12/12/2025, Saintil sold 15,000 shares of Rocket Lab common stock at $65 per share in a disposition coded “S.” After this transaction, Saintil directly owned 398,529 shares of Rocket Lab common stock.
Rocket Lab Corp (RKLB) Chief Financial Officer Adam Spice reported stock sales in a Form 4 filing. On 11/22/2025, he sold 15,633 shares of common stock in a sell-to-cover transaction at a weighted average price of $40.0247 to satisfy tax withholding from vested restricted stock units. On 11/24/2025, he sold an additional 46,737 shares at a weighted average price of $40.8576 and 257 shares at a weighted average price of $41.3495, also reported as sales.
After these transactions, Spice beneficially owned 1,995,373 Rocket Lab common shares, which includes 111 shares acquired under the company’s 2021 Employee Stock Purchase Plan in transactions exempt under Rule 16b-3. The reported sale prices reflect weighted averages for multiple trades within specified price ranges.
Rocket Lab Corp (RKLB) reported an insider stock transaction by its Chief Operations Officer, Frank Klein. On 11/24/2025, Klein sold 10,430, 31,181, and 171 shares of common stock in three separate transactions at weighted average prices of $40.0247, $40.8576, and $41.3495 per share, respectively.
The filing states these sales were part of a “sell-to-cover” arrangement to satisfy tax withholding obligations related to vesting restricted stock units previously granted to him. After these transactions, Klein beneficially owned 1,274,223 Rocket Lab common shares, held directly.
Rocket Lab Corp (RKLB) reported insider share sales by its SVP General Counsel in a Form 4 filing. On 11/24/2025, the executive sold 7,143, 21,355, and 117 shares of common stock in three separate transactions at weighted average prices of $40.0247, $40.8576, and $41.3495, respectively. These sales were executed as part of a sell-to-cover transaction to satisfy tax withholding obligations related to vesting restricted stock units.
Following these trades, the reporting person directly beneficially owns 461,014 Rocket Lab common shares. The prices reported reflect weighted averages for shares sold in multiple trades within the noted price ranges, and detailed breakdowns are available on request to the company or regulators.
Rocket Lab Corp (RKLB) CEO and Director Peter Beck reported equity awards and related share sales. On 11/15/2025, he was granted 132,426 restricted stock units (RSUs) under the Rocket Lab Corporation 2021 Stock Option and Incentive Plan at a price of $0.0. These RSUs vest over time, with 1/16 vesting on November 22, 2025 and 1/16 on each March 1, May 22, August 22 and November 22 thereafter, subject to his continuous service.
On 11/24/2025, Beck sold 4,707, 14,073 and 77 common shares in three separate transactions as sell-to-cover sales to satisfy tax withholding related to RSU vesting. The weighted average sale prices were $40.0247, $40.8576 and $41.3495, each executed in multiple trades within specified price ranges. After these transactions, he directly owned 902,942 Rocket Lab shares and was also reported as an indirect beneficial owner of 2,500,000 shares held by a family trust.
Rocket Lab Corp director Jon A. Olson reported selling 60,400 shares of Rocket Lab common stock in an open-market transaction on 11/20/2025 at a weighted average price of $45.0244 per share.
Following this sale, Olson directly beneficially owned 375,835 Rocket Lab shares. The filing notes that the reported price is a weighted average, as the shares were sold in multiple trades at prices ranging from $45 to $45.110 per share.